News
Hier finden Sie Neuigkeiten rund um die Medizinische Fakultät Zürich.
News list
-
New NCCR for Pediatric Oncology at University of Zurich
The University of Zurich has been awarded National Centre of Competence in Research to revolutionize childhood cancer treatment. This long-term initiative aims to bridge the gap between basic research and clinical application for young patients.
-
UZH Innovation Hub Launches New Support Programs for Researchers
The UZH Innovation Hub empowers master graduates and early career researchers to transform research-based ideas into real-world applications. Two major funding programs and a workshop series are now open for applications.
-
Citizen Science Seed Grants 2026: Applications Open in November 202
Citizen Science Zurich, a center at the University of Zurich, promotes public participation in science and awards Seed Grants of up to CHF 40,000 for participatory Citizen Science projects. The application period for 2026 is expected to open in November 2025.
-
Call for Sustainability Projects at UZH Faculty of Medicine
The University of Zurich’s Faculty of Medicine is funding sustainability projects in 2026 with up to CHF 15,000 per project. Applications are open until March 31, 2026.
-
Broermann Medical Innovation Award 2026
The Broermann Medical Innovation Award, endowed with €1 million annually, honors scientists whose groundbreaking work advances . Nominations for the 2026 award are now open.
-
True IMPACT 2026 Conference
The program for the True IMPACT – Delivering Innovation for Patients and the Public conference, the 4th Swiss Implementation Science Conference, is now available online. The event will take place on February 12–13, 2026, at the University of Zurich, bringing together researchers, practitioners, and policymakers to discuss how implementation science can effectively translate innovations from research into real-world practice.
-
Call for Applications: Johann-Georg-Zimmermann Award 2026 for Cancer Research
The prestigious Johann-Georg-Zimmermann Award is one of Germany’s highest honors in cancer research. This two-part award recognizes both young researchers and individuals who have made outstanding contributions to cancer prevention. Applications and nominations are open until January 31, 2026.
-
Breakthrough: How Epstein-Barr Virus May Trigger Multiple Sclerosis
Researchers led by Prof. Christian Münz at the University of Zurich have uncovered a key mechanism by which Epstein-Barr virus (EBV) may trigger multiple sclerosis (MS). The study, published in Nature, reveals that EBV-infected B cells migrate to the central nervous system, attracting T cells and promoting inflammation—a potential target for new therapies.
-
Lohfert Prize 2026: Innovative Solutions for the Patient Journey Sought
The Christoph Lohfert Foundation has announced the Lohfert Prize 2026, focusing on innovative projects that improve the patient journey across institutions. The prize, endowed with €20,000, is supported by Stefan Schwartze, the German Government’s Commissioner for Patients’ Rights.
-
-
EBRAINS Summit 2025
The EBRAINS Summit 2025, Europe’s premier neuroscience conference, will gather leading researchers, policymakers, and innovators in Brussels from 8–11 December 2025. This groundbreaking event aims to accelerate brain research, foster interdisciplinary collaboration, and drive innovation in medicine and neurotechnology.